Evidence map›Paper›PMID 33256439›Full record

ReviewThe American journal of psychiatry2020

Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse.

Joseph T Coyle, W Brad Ruzicka, Darrick T Balu

Abstract readHistorical ArticleReview
In one paragraph

Review in The American journal of psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Novel drug treatments for schizophrenia.Nature reviews. Drug discovery · 2026
    Review
  8. UntargetedTranslational psychiatry · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Early postnatal NMDA receptor ablation in cortical interneurons impairs affective state discrimination and social functioning.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  17. Article
  18. Future Perspectives of NMDAR in CNS Disorders.Molecules (Basel, Switzerland) · 2025
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph T CoyleHarvard Medical School and McLean Hospital, Belmont, Mass.
W Brad RuzickaHarvard Medical School and McLean Hospital, Belmont, Mass.
Darrick T BaluHarvard Medical School and McLean Hospital, Belmont, Mass.

Funding

Stabilizing the Tripartite Synaptic Complex Following TBIR01NS098740 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Joacir Graciolli Graciolli Cordeiro, Daniel Jon Liebl · 2017 to 2026
$4.7M
Neuronal and circuitry specific chromatin dynamics in psychotic disordersK08MH109759 · NIMH · MCLEAN HOSPITAL · PI RUZICKA, WILLIAM B · 2016 to 2019
$788k
Defining the Role of Glial D-serine in Alzheimer's DiseaseR03AG063201 · NIA · MCLEAN HOSPITAL · PI BALU, DARRICK T · 2019 to 2020
$328k
NIA NIH HHS R03 AG063201NIMH NIH HHS K08 MH109759NINDS NIH HHS R01 NS098740
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

History, 20th CenturyHistory, 21st CenturyHumansReceptors, GlutamateResearchSchizophreniaSynaptic TransmissionReceptors, GlutamateAntipsychoticsGenetics/GenomicsHistory of PsychiatryNeuropathologySchizophrenia Spectrum and Other Psychotic Disorders

Identifiers

PMID33256439
PMCPMC8011846

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.